\-\ Texto\\:\\ \ \(0\)\
\-\ pulmonary\\ \\-\\ bilbasilar\\ rhonci\\,\\ increased\\ sob\ \(0\)\
\-\ cbc\\ \\-\\ 5\\.2\\/13\\.8\\/40\\.9\\/241\ \(0\)\
\-\ bmp\\ \\-\\ 145\\/3\\.4\\/104\\/31\\/13\\/1\\.0\\/87\ \(0\)\
\-\ ck\\ \\-\\ 104\ \(0\)\
\-\ high\\ dose\\ prednisone\\ 1\\ mg\\/kg\ \(0\)\
\-\ methotrexate\ \(25\)\
\-\ pulmonary\\ fibrosis\\ in\\ a\\ bibasilar\\ pattern\\.\\ \\ characterisitc\\ honeycomb\\ pattern\\ commonly\\ seen\\ in\\ interstitial\\ lung\\ disease\\.\ \(0\)\
\-\ interstitial\\ lung\\ disease\ \(17\)\
\-\ dermatomyositis\\ \ \(2\)\
\-\ other\\ connective\\ tissue\\ disease\ \(1\)\
\-\ asbestos\ \(71\)\
\-\ radiation\ \(402\)\
\-\ medication\\ side\\ effect\ \(1\)\
\-\ 63\\ yo\\ male\\ with\\ hx\\ of\\ dermatomyositis\\ c\\/o\\ increased\\ sob\ \(0\)\
\-\ interstitial\\ lung\\ disease\\ is\\ seen\\ in\\ approximately\\ 10\\%\\ of\\ cases\\ of\\ dermatomyositis\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ dermatomyositis\\:\\ 0\\.4098699206483049\ \(0\)\
\-\ interstitial\\:\\ 0\\.30094092702814745\ \(0\)\
\-\ 104\\:\\ 0\\.25593224669731\ \(0\)\
\-\ sob\\:\\ 0\\.22904057842852374\ \(0\)\
\-\ lung\\:\\ 0\\.20193743278646298\ \(0\)\
\-\ disease\\:\\ 0\\.18579549520379818\ \(0\)\
\-\ bilbasilar\\:\\ 0\\.17696080928594768\ \(0\)\
\-\ characterisitc\\:\\ 0\\.17696080928594768\ \(0\)\
\-\ rhonci\\:\\ 0\\.1690955005264112\ \(0\)\
\-\ pattern\\:\\ 0\\.16522793779375838\ \(0\)\
\-\ honeycomb\\:\\ 0\\.14778435763248157\ \(0\)\
\-\ ck\\:\\ 0\\.1406511447458952\ \(0\)\
\-\ pulmonary\\:\\ 0\\.13489817094302475\ \(0\)\
\-\ asbestos\\:\\ 0\\.127966123348655\ \(0\)\
\-\ bmp\\:\\ 0\\.12576774651319586\ \(0\)\
\-\ bibasilar\\:\\ 0\\.1250870367318214\ \(0\)\
\-\ methotrexate\\:\\ 0\\.12442940635617515\ \(0\)\
\-\ increased\\:\\ 0\\.11967350160324329\ \(0\)\
\-\ prednisone\\:\\ 0\\.11656409759663866\ \(0\)\
\-\ connective\\:\\ 0\\.11491218614362342\ \(0\)\
\-\ 63\\:\\ 0\\.10691536340084477\ \(0\)\
\-\ seen\\:\\ 0\\.10419058788781187\ \(0\)\
\-\ dose\\:\\ 0\\.10333500580902207\ \(0\)\
\-\ medication\\:\\ 0\\.10227472890154095\ \(0\)\
\-\ hx\\:\\ 0\\.10069031899807071\ \(0\)\
\-\ fibrosis\\:\\ 0\\.09269863690411673\ \(0\)\
\-\ cbc\\:\\ 0\\.09232438275744138\ \(0\)\
\-\ in\\:\\ 0\\.08258182652651774\ \(0\)\
\-\ commonly\\:\\ 0\\.08187909927140753\ \(0\)\
\-\ effect\\:\\ 0\\.07762275428516759\ \(0\)\
\-\ side\\:\\ 0\\.07644333754023581\ \(0\)\
\-\ cases\\:\\ 0\\.07442679302492794\ \(0\)\
\-\ radiation\\:\\ 0\\.07332893678178792\ \(0\)\
\-\ approximately\\:\\ 0\\.07060569886079231\ \(0\)\
\-\ yo\\:\\ 0\\.06913072252673062\ \(0\)\
\-\ of\\:\\ 0\\.0649638515713927\ \(0\)\
\-\ 10\\:\\ 0\\.0647051952910185\ \(0\)\
\-\ high\\:\\ 0\\.06288882951810494\ \(0\)\
\-\ tissue\\:\\ 0\\.058046913732647594\ \(0\)\
\-\ other\\:\\ 0\\.057464714974600546\ \(0\)\
\-\ male\\:\\ 0\\.04926768859660321\ \(0\)\
\-\ is\\:\\ 0\\.03030351644853457\ \(0\)\
\-\ with\\:\\ 0\\.021667555819075524\ \(0\)\
